An Observational Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in China
Phase of Trial: Phase IV
Latest Information Update: 06 Aug 2018
At a glance
- Drugs Bortezomib (Primary) ; Bortezomib (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- Sponsors Xian-Janssen
- 26 Jul 2018 Planned End Date changed from 19 Dec 2019 to 19 Jan 2019.
- 28 Jun 2018 Planned End Date changed from 31 Dec 2018 to 19 Dec 2019.
- 06 Jun 2017 Status changed from not yet recruiting to recruiting.